1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with sdz 64-412 in 6 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (sdz 64-412) | Trials (sdz 64-412) | Recent Studies (post-2010) (sdz 64-412) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 6 | 0 | 0 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | sdz 64-412 (IC50) |
|---|---|---|---|
| Platelet-activating factor receptor | Homo sapiens (human) | 0.06 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Handley, DA; Havill, AM; Van Valen, RG | 1 |
| Beattie, LL; Ishida, K; Schellenberg, RR; Thomson, RJ; Wiggs, B | 1 |
| Handley, DA; Houlihan, WJ; Melden, MK; Saunders, RN; Van Valen, RG | 1 |
| Athill, LV; Charnick, SB; Karara, AH; Lau, DT; Tse, FL; Yu, Z | 1 |
| Cheon, SH; Handley, DA; Houlihan, WJ; Larson, DA; Parrino, VA | 1 |
| Fleming, TP; Stoddart, NR; Wild, AE | 1 |
6 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sdz 64-412
| Article | Year |
|---|---|
Prevention of non-specific airway hyperreactivity after allergen challenge in guinea-pigs by the PAF receptor antagonist SDZ 64-412.
Topics: Allergens; Animals; Azepines; Bronchi; Bronchoalveolar Lavage Fluid; Eosinophils; Guinea Pigs; Histamine; Hypersensitivity; In Vitro Techniques; Isoquinolines; Male; Methylprednisolone; Platelet Activating Factor; Triazines; Triazoles; Vagotomy; Vagus Nerve | 1990 |
Inhibition of antigen-induced airway hyperresponsiveness, but not acute hypoxia nor airway eosinophilia, by an antagonist of platelet-activating factor.
Topics: Acetylcholine; Airway Resistance; Animals; Bronchial Provocation Tests; Bronchial Spasm; Connective Tissue Cells; Eosinophils; Epithelial Cells; Guinea Pigs; Hypersensitivity; Isoquinolines; Ovalbumin; Platelet Activating Factor; Platelet Aggregation; Respiratory System | 1990 |
Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412.
Topics: Adenosine Diphosphate; Animals; Blood Pressure; Bronchi; Cebus; Collagen; Dogs; Dose-Response Relationship, Drug; Epinephrine; Guinea Pigs; Isoquinolines; Mice; Platelet Activating Factor; Platelet Aggregation; Rats | 1988 |
Pharmacokinetics of SDZ 64-412, a novel antiasthmatic agent, following intravenous, oral, and inhalation dosing in the rat.
Topics: Administration, Inhalation; Administration, Oral; Animals; Atmosphere Exposure Chambers; Biological Availability; Dose-Response Relationship, Drug; Half-Life; Injections, Intravenous; Intestinal Absorption; Isoquinolines; Metabolic Clearance Rate; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1994 |
Structural modification of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinoline platelet activating factor receptor antagonists.
Topics: Animals; Binding, Competitive; Bronchoconstriction; Guinea Pigs; Humans; Isoquinolines; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridines; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Thienopyridines; Thiophenes | 1993 |
Stimulation of development in vitro by platelet-activating factor receptor ligands released by mouse preimplantation embryos.
Topics: Animals; Blastocyst; Cell Culture Techniques; Embryonic and Fetal Development; Isoquinolines; Mice; Mice, Inbred Strains; Phospholipid Ethers; Platelet Activating Factor; Stimulation, Chemical | 1996 |